4/A
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001214659-22-004992
Director sold 25,000 shares at $1.21 ($30,325)
From the SEC's structured data for this filing
Trades in this filing
McGrath Lynne Fahey · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-28 | Sale : show line 1 in the form | −25,000 | $1.21 | $30,325 | 75,000 | D |
| Open-market sales · 25,000 sh · avg $1.21 · $30,325 | ||||||
Loading xslF345X03/marketforms-55978.xml…